BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19551841)

  • 1. Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.
    Sounni NE; Rozanov DV; Remacle AG; Golubkov VS; Noel A; Strongin AY
    Int J Cancer; 2010 Mar; 126(5):1067-78. PubMed ID: 19551841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
    Chernov AV; Sounni NE; Remacle AG; Strongin AY
    J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.
    Takino T; Miyamori H; Watanabe Y; Yoshioka K; Seiki M; Sato H
    Cancer Res; 2004 Feb; 64(3):1044-9. PubMed ID: 14871836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
    Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
    Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis.
    Valacca C; Tassone E; Mignatti P
    PLoS One; 2015; 10(9):e0136797. PubMed ID: 26331622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
    D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
    J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM; Kim A; Oh JH; Chung AS
    Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
    Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
    Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C; Chen Z; Li Z; Cen J
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
    Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
    J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
    Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
    J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.
    Jiang B; Zhang Y; Liu J; Tsigkou A; Rapti M; Lee MH
    Oncotarget; 2017 Apr; 8(14):22685-22699. PubMed ID: 28186971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
    Miller MC; Manning HB; Jain A; Troeberg L; Dudhia J; Essex D; Sandison A; Seiki M; Nanchahal J; Nagase H; Itoh Y
    Arthritis Rheum; 2009 Mar; 60(3):686-97. PubMed ID: 19248098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
    Roy S; Chakraborti T; Chowdhury A; Chakraborti S
    J Biochem; 2013 Mar; 153(3):289-302. PubMed ID: 23266860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.